Article Versions Notes

Salvo M, González-Feliú E, Toro J, Gallegos I, Maureira I, Miranda-González N, Barajas O, Bustamante E, Ahumada M, Colombo A, et al. Validation of an NGS Panel Designed for Detection of Actionable Mutations in Tumors Common in Latin America. Journal of Personalized Medicine. 2021; 11(9):899. https://doi.org/10.3390/jpm11090899

Salvo, Mauricio, Evelin González-Feliú, Jessica Toro, Iván Gallegos, Ignacio Maureira, Nicolás Miranda-González, Olga Barajas, Eva Bustamante, Mónica Ahumada, Alicia Colombo, and et al. 2021. "Validation of an NGS Panel Designed for Detection of Actionable Mutations in Tumors Common in Latin America" Journal of Personalized Medicine 11, no. 9: 899. https://doi.org/10.3390/jpm11090899

Salvo, M., González-Feliú, E., Toro, J., Gallegos, I., Maureira, I., Miranda-González, N., Barajas, O., Bustamante, E., Ahumada, M., Colombo, A., Armisén, R., Villamán, C., Ibañez, C., Bravo, M. L., Sanhueza, V., Spencer, M. L., de Toro, G., Morales, E., Bizama, C., ... Marcelain, K. (2021). Validation of an NGS Panel Designed for Detection of Actionable Mutations in Tumors Common in Latin America. Journal of Personalized Medicine, 11(9), 899. https://doi.org/10.3390/jpm11090899